MA49986A - Procédés de préparation d'oligomères morpholino phosphorodiamidate par l'intermédiaire d'une synthèse à flux rapide - Google Patents
Procédés de préparation d'oligomères morpholino phosphorodiamidate par l'intermédiaire d'une synthèse à flux rapideInfo
- Publication number
- MA49986A MA49986A MA049986A MA49986A MA49986A MA 49986 A MA49986 A MA 49986A MA 049986 A MA049986 A MA 049986A MA 49986 A MA49986 A MA 49986A MA 49986 A MA49986 A MA 49986A
- Authority
- MA
- Morocco
- Prior art keywords
- processes
- rapid flow
- via rapid
- flow synthesis
- oligomers via
- Prior art date
Links
- WROTXLSEMHAZEA-UHFFFAOYSA-N 4-diaminophosphoryloxymorpholine Chemical compound NP(N)(=O)ON1CCOCC1 WROTXLSEMHAZEA-UHFFFAOYSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
- C08G79/02—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/314—Phosphoramidates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/323—Chemical structure of the sugar modified ring structure
- C12N2310/3233—Morpholino-type ring
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2330/00—Production
- C12N2330/30—Production chemically synthesised
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Luminescent Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762562741P | 2017-09-25 | 2017-09-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA49986A true MA49986A (fr) | 2020-07-01 |
Family
ID=65810587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA049986A MA49986A (fr) | 2017-09-25 | 2018-09-25 | Procédés de préparation d'oligomères morpholino phosphorodiamidate par l'intermédiaire d'une synthèse à flux rapide |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20200362339A1 (fr) |
| EP (1) | EP3672601B1 (fr) |
| JP (1) | JP7218361B2 (fr) |
| ES (1) | ES2963336T3 (fr) |
| MA (1) | MA49986A (fr) |
| TW (1) | TWI812647B (fr) |
| WO (1) | WO2019060862A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7689078B2 (ja) * | 2019-11-13 | 2025-06-05 | 日本新薬株式会社 | オリゴ核酸化合物の製造方法 |
| US20230235328A1 (en) * | 2020-06-05 | 2023-07-27 | Nexoligo Co., Ltd. | Novel morpholino oligonucleotide derivatives |
| US12378267B2 (en) | 2021-06-17 | 2025-08-05 | Entrada Therapeutics, Inc. | Synthesis of FMOC-protected morpholino monomers and oligomers |
| WO2023205451A1 (fr) | 2022-04-22 | 2023-10-26 | Entrada Therapeutics, Inc. | Peptides cycliques pour administrer des agents thérapeutiques |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2657400T3 (es) * | 2006-05-10 | 2018-03-05 | Sarepta Therapeutics, Inc. | Análogos de oligonucleótidos que tienen enlaces intersubunitarios catiónicos |
| CA2884340C (fr) * | 2007-11-15 | 2017-07-25 | Sarepta Therapeutics, Inc. | Procede de synthese d'oligomeres morpholino |
| CA2779830C (fr) * | 2009-11-13 | 2020-07-21 | Avi Biopharma, Inc. | Compose antiviral antisens et methode de traitement d'une infection par le virus grippal |
| PL2623507T3 (pl) * | 2010-09-30 | 2017-03-31 | Nippon Shinyaku Co., Ltd. | Pochodna kwasu morfolinonukleinowego |
| KR20230074606A (ko) * | 2013-03-14 | 2023-05-30 | 사렙타 쎄러퓨틱스 인코퍼레이티드 | 근육 이영양증의 치료를 위한 엑손 스키핑 조성물 |
| CN105228999B (zh) * | 2013-05-24 | 2021-03-02 | 味之素株式会社 | 吗啉代寡核苷酸的制备方法 |
| IL282239B2 (en) * | 2013-09-05 | 2023-10-01 | Sarepta Therapeutics Inc | Antisense-induced exon2 inclusion in acid alpha-glucosidase |
| RU2702424C2 (ru) * | 2014-03-12 | 2019-10-08 | Ниппон Синяку Ко., Лтд. | Антисмысловые нуклеиновые кислоты |
| WO2017062835A2 (fr) * | 2015-10-09 | 2017-04-13 | Sarepta Therapeutics, Inc. | Compositions et méthodes pour traiter la dystrophie musculaire de duchenne et troubles associés |
| CN109563114B (zh) * | 2016-05-24 | 2022-08-12 | 萨勒普塔医疗公司 | 用于制备寡聚物的方法 |
| MX383656B (es) * | 2016-05-24 | 2025-03-14 | Sarepta Therapeutics Inc | Procesos para preparar oligómeros de morfolino fosforodiamidato. |
| KR102523527B1 (ko) * | 2016-06-30 | 2023-04-20 | 사렙타 쎄러퓨틱스 인코퍼레이티드 | 포스포로디아미데이트 모르폴리노 올리고머의 제조 방법 |
-
2018
- 2018-09-25 TW TW107133695A patent/TWI812647B/zh active
- 2018-09-25 WO PCT/US2018/052524 patent/WO2019060862A1/fr not_active Ceased
- 2018-09-25 ES ES18859106T patent/ES2963336T3/es active Active
- 2018-09-25 US US16/650,305 patent/US20200362339A1/en not_active Abandoned
- 2018-09-25 JP JP2020516835A patent/JP7218361B2/ja active Active
- 2018-09-25 EP EP18859106.9A patent/EP3672601B1/fr active Active
- 2018-09-25 MA MA049986A patent/MA49986A/fr unknown
-
2024
- 2024-06-20 US US18/749,007 patent/US20250043283A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW201919659A (zh) | 2019-06-01 |
| TWI812647B (zh) | 2023-08-21 |
| WO2019060862A1 (fr) | 2019-03-28 |
| EP3672601A4 (fr) | 2021-05-12 |
| JP7218361B2 (ja) | 2023-02-06 |
| JP2020535141A (ja) | 2020-12-03 |
| ES2963336T3 (es) | 2024-03-26 |
| EP3672601B1 (fr) | 2023-09-13 |
| US20250043283A1 (en) | 2025-02-06 |
| EP3672601A1 (fr) | 2020-07-01 |
| US20200362339A1 (en) | 2020-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA45155A (fr) | Procédés de préparation d'oligomères morpholino de phosphorodiamidate | |
| MA45183A (fr) | Procédés de préparation d'oligomères morpholino de phosphorodiamidate | |
| MA49775A (fr) | Procédés de préparation d'oligomères morpholino de phosphorodiamidate | |
| EP3980073A4 (fr) | Procédés de préparation de complexes protéine-oligonucléotide | |
| GB2567754B (en) | Flow path sensing for flow therapy apparatus | |
| EP3307266A4 (fr) | Nouvelles polythérapies à base de cannabinoïdes pour le myélome multiple (mm) | |
| MA49986A (fr) | Procédés de préparation d'oligomères morpholino phosphorodiamidate par l'intermédiaire d'une synthèse à flux rapide | |
| EP3302507A4 (fr) | Procédés de diagnostic pour thérapie par lymphocytes t | |
| EP3387189A4 (fr) | Système pour coordonner des machines de fraisage et de pavage | |
| GB2562911B (en) | Flow path sensing for flow therapy apparatus | |
| MA41962A (fr) | Récepteur antigénique chimérique ciblant le cd5 pour une thérapie adoptive à base de cellules t | |
| DK3609540T3 (da) | Fremgangsmåde til immunkonjugatsyntese | |
| EP3509982A4 (fr) | Distributeur proactif pour système d'alerte mobile d'opérateur | |
| EP3631564A4 (fr) | Système à réalité augmentée à fixation amovible pour lunettes | |
| EP3367890A4 (fr) | Procédés de radiothérapie pour déclencher des médicaments à photoactivation | |
| MA45362A (fr) | Procédés de préparation d'oligomères morpholino de phosphorodiamidate | |
| EP3360893A4 (fr) | Molécule de pdl-1 soluble à forte affinité | |
| EP3500286A4 (fr) | Synthèse d'échelle d'elamipretide à base de n-carboxyanhydride | |
| EP3334464A4 (fr) | Conjugués chélatés à base de manganèse pour l'imagerie par résonance magnétique moléculaire | |
| EP3766869A4 (fr) | Procédé simple de préparation d'avibactam | |
| EP3681697A4 (fr) | Supports thermiques pour éléments 3d formés à partir de particules | |
| EP2817473A4 (fr) | Appareil pour régler l'alignement de machines à forer | |
| EP3317004A4 (fr) | Appareil de préparation d'une solution, et procédés associés | |
| EP3288712C0 (fr) | Dispositif servant à l'usinage de surface | |
| EP3283852A4 (fr) | Guide de support de plaque pour raccord à orifice |